New Key Statistics Module, Z-Score and F-Score
OTCPK:TLTFF Key Ratios
| Market Cap $ M | 27.88 |
| Enterprise Value $ M | 28.13 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 20.00 |
| Price/Sales | 40.00 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -0.01 |
| Beneish M-Score | -2.66 |
| 10-y EBITDA Growth Rate % | 5.30 |
| 5-y EBITDA Growth Rate % | 9.70 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -11.39 |
| EV-to-EBITDA | -11.89 |
| PEG | -- |
| Shares Outstanding M | 239.30 |
| Net Margin (%) | -400.94 |
| Operating Margin % | -402.93 |
| Pre-tax Margin (%) | -400.94 |
| Quick Ratio | 0.78 |
| Current Ratio | 1.39 |
| ROA % (ttm) | -100.18 |
| ROE % (ttm) | -161.13 |
| ROIC % (ttm) | -170.41 |
| Dividend Yield % | -- |
| Altman Z-Score | -14.05 |
TLTFF Number of Guru Trades
TLTFF Volume of Guru Trades
Gurus Latest Trades with OTCPK:TLTFF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:TLTFF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Theralase Technologies Inc Insider Transactions
No Available Data
News about OTCPK:TLTFF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers